SFX by Ex Libris Inc.

Title:	Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine
Source:	International Journal of Cancer [0020-7136] Karan, Dev yr:2007

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Park, Tae Gwan G. "Current status of polymeric gene delivery systems." Advanced drug delivery reviews 58.4 (2006): 467-486.
description	2.	Li Q, Q. "Enhanced immune responses induced by vaccine using Sendai virosomes as carrier." International Journal of Pharmaceutics 329.1-2 (2007): 117-121.
description	3.	Lubaroff, David M M. "Clinical protocol: phase I study of an adenovirus/prostate-specific antigen vaccine in men with metastatic prostate cancer." Human gene therapy 17.2 (2006): 220-9.
description	4.	Ivanov, S. "A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA." Blood 110.6 (2007): 1970-81.
description	5.	JEONG, Ji n. "Molecular design of functional polymers for gene therapy." Progress in polymer science 32.11 (2007): 1239-1274.
description	6.	Kam, Nadine g. "Functionalization of Carbon Nanotubes via Cleavable Disulfide Bonds for Efficient Intracellular Delivery of siRNA and Potent Gene Silencing." Journal of the American Chemical Society 127.36 (2005): 12492-12493.
description	7.	Torchilin, Vladimir P. "Multifunctional nanocarriers." Advanced drug delivery reviews 58.14 (2006): 1532-1555.
description	8.	Leong, M. "Natural polymers for gene delivery and tissue engineering." Advanced drug delivery reviews 58.4: 487-499.
description	9.	Nishiyama, N. "Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery." Pharmacology & therapeutics 112.3: 630-648.
description	10.	"Virosome: An engineered virus for vaccine delivery." Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society. 31.5: 752-764.
description	11.	Ishikawa, E. "Clinical trial of autologous formalin-fixed tumor vaccine for glioblastoma multiforme patients." Cancer Science 98.8 (2007): 1226-1233.
description	12.	LUBAROFF, David M M. "Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer." Vaccine 24.35-36 (2006): 6155-62.
description	13.	Arkema, A. "Induction of cytotoxic T lymphocyte activity by fusion-active peptide-containing virosomes." Vaccine 18.14: 1327-1333.
description	14.	Lee, Jeong-Won W. "Increased toll-like receptor 9 expression in cervical neoplasia." Molecular carcinogenesis 46.11 (2007): 941-7.
description	15.	Patel, Punam H H. "Sipuleucel-T : a vaccine for metastatic, asymptomatic, androgen-independent prostate cancer." The Annals of pharmacotherapy 42.1 (2008): 91-98.
description	16.	van Beijnum, Judy R R. "Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1)." Angiogenesis 11.1 (2008): 91-9.
description	17.	Obonyo, M. "Deficiencies of Myeloid differentiation factor 88, Toll-like receptor (TLR)-2, or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori." Infection and immunity 75.5 (2007): 2408-2414.
description	18.	Lutgendorf, Susan K K. "Social Support, Psychological Distress, and Natural Killer Cell Activity in Ovarian Cancer." Journal of clinical oncology 23.28 (2005): 7105-7113.
description	19.	Tian, J. "Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE." Nature immunology 8.5 (2007): 487-96.
description	20.	Kazama, H. "Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein." Immunity 29.1 (2008): 21-32.